Menu Back to Excellence-in-Pharmacovigilance-Clinical-trials-and-post-marketing

Overview

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

Program Committee

  • Gaby L. Danan, MD, PhD
    Gaby L. Danan, MD, PhD Pharmacovigilance Expert
    GLD Conseil, France
  • Phil  Tregunno
    Phil Tregunno Signal Management & Quality Standards Unit Manager
    MHRA, United Kingdom
Load More